Research Atlas · source screening

Voclosporin

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Title-search results

100

Shown with stable PMIDs

25

Search recorded

2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Voclosporin"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

1. Safety and efficacy of adding voclosporin to standard treatment of lupus nephritis in adult patients: a meta-analysis and time-to-event analysis of randomized controlled trials.

   Int Urol Nephrol · 2026 Sep · PMID 41922881 · DOI 10.1007/s11255-026-05058-8

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

2. Voclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series.

   J Nephrol · 2026 Aug 12 · PMID 42584031 · DOI 10.1093/joneph/aajag126

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

3. Voclosporin Preserves Mitochondrial Function Compared With Cyclosporine A in Perfused Human Proximal Tubule Microphysiological Systems.

   bioRxiv · 2026 Jul 11 · PMID 42465467 · DOI 10.64898/2026.07.07.737071

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

4. Immunosuppressive effects of voclosporin in inflammatory bowel disease through targeted inhibition of SLP-76 and metabolic reprogramming.

   J Immunol · 2026 Jul 10 · PMID 42501366 · DOI 10.1093/jimmun/vkag175

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

5. Evaluation of Puromycin-Induced Podocyte Injury and Protective Effects of Voclosporin Using Induced Pluripotent Stem Cells from a Patient with Nephrotic Syndrome Harboring an INF2 Variant.

   Stem Cells Dev · 2026 Jul · PMID 42310862 · DOI 10.1177/15473287261460636

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

6. Long-term safety and efficacy of voclosporin in Asian patients with lupus nephritis: A post hoc analysis of the AURORA 2 trial.

   Mod Rheumatol · 2026 Jun 30 · PMID 41410387 · DOI 10.1093/mr/roaf121

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

7. Does Voclosporin Redefine Lupus Nephritis Treatment? A Tri-Focal View of Efficacy, Safety, and Costs.

   Curr Med Sci · 2026 Jun · PMID 42262645 · DOI 10.1007/s11596-026-00217-5

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

8. Voclosporin-induced gingival enlargement: A case report.

   Clin Adv Periodontics · 2026 Jun · PMID 40569085 · DOI 10.1002/cap.10369

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

9. A case of lupus nephritis achieving early remission using a treatment protocol similar to the AURORA trial with voclosporin and successfully discontinuing corticosteroids early.

   CEN Case Rep · 2026 May 22 · PMID 42171925 · DOI 10.1007/s13730-026-01133-2

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

10. Methodological considerations on the safety and efficacy of adding voclosporin to standard treatment for lupus nephritis: a commentary.

    Int Urol Nephrol · 2026 May 8 · PMID 42101735 · DOI 10.1007/s11255-026-05186-1

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

11. Voclosporin and Changes in Blood Pressure: An Analysis of Real-World Data.

    Arthritis Care Res (Hoboken) · 2026 May 4 · PMID 42080617 · DOI 10.1002/acr.80082

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

12. Case Series of the Combination of Voclosporin and Belimumab Treatment of Lupus Nephritis.

    Glomerular Dis · 2026 Jan-Dec · PMID 42389424 · DOI 10.1159/000552239

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

13. The Inverted Pyramid Approach: Early Combination Therapy With Voclosporin and Obinutuzumab in Active Lupus Nephritis.

    Cureus · 2026 Apr · PMID 42038730 · DOI 10.7759/cureus.107549

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

14. High-Dose Voclosporin Protects Against Acute Kidney Injury via Regnase-2-Mediated NGAL MRNA Decay.

    Int J Mol Sci · 2026 Mar 30 · PMID 41977336 · DOI 10.3390/ijms27073150

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

15. Rapid Reduction in Proteinuria With the Initiation of Voclosporin in Lupus Nephritis: A Single-Center Experience.

    Cureus · 2026 Mar · PMID 42011456 · DOI 10.7759/cureus.105557

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

16. Single-center experience of voclosporin use for pediatric lupus nephritis: a case series.

    Rheumatology (Oxford) · 2026 Mar 5 · PMID 41834110 · DOI 10.1093/rheumatology/keag125

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

17. Voclosporin ameliorates proteinuria in a model of non-inflammatory glomerular disease.

    BMC Nephrol · 2026 Feb 24 · PMID 41735917 · DOI 10.1186/s12882-026-04837-w

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

18. Voclosporin shows protective effect and intestinal barrier enforcement in experimental colitis.

    Front Med (Lausanne) · 2026 · PMID 41704697 · DOI 10.3389/fmed.2026.1750826

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

19. Two-Hour Post-dose (C2)-Monitored Cyclosporine Microemulsion as a Practical Alternative to Voclosporin in Mixed Class IV/V Lupus Nephritis: A Case Report.

    Cureus · 2026 Jan · PMID 41769630 · DOI 10.7759/cureus.102585

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

20. Early antiproteinuric effect of voclosporin in patients with LN in a real-life setting: preliminary results from the VoRLiSS (Voclosporin in Real Life Setting Study) experience.

    Rheumatology (Oxford) · 2026 Jan 8 · PMID 41386258 · DOI 10.1093/rheumatology/keaf654

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

21. Investigation of Renal Tissue Deposition of the Calcineurin Inhibitors Voclosporin, Cyclosporine and Tacrolimus Using MALDI-MSI Imaging.

    Pharm Res · 2026 Jan · PMID 41507552 · DOI 10.1007/s11095-025-03943-y

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

22. Clinical adverse events to voclosporin: a real-world drug safety study based on the FDA Adverse Event Reporting System.

    Clin Exp Rheumatol · 2026 Jan · PMID 40737084 · DOI 10.55563/clinexprheumatol/qhyux8

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

23. Safety assessment of voclosporin: a real-world disproportionality analysis of the FAERS database.

    Immunopharmacol Immunotoxicol · 2025 Dec · PMID 41097907 · DOI 10.1080/08923973.2025.2572075

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

24. "Voclosporin in late onset lupus nephritis with anti-PLA2R antibodies".

    Semin Arthritis Rheum · 2025 Dec · PMID 41075384 · DOI 10.1016/j.semarthrit.2025.152835

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

25. Response: Does baseline nephrotic range proteinuria determine the long-term outcomes of membranous lupus nephritis patients? Reply Letter to Capuano et al. (Letter to the Editor: Voclosporin in Late Onset Lupus Nephritis with Anti-PLA2R Antibodies).

    Semin Arthritis Rheum · 2025 Dec · PMID 41027045 · DOI 10.1016/j.semarthrit.2025.152836

    Source metadata only · evidence grade unassigned · scientific conclusions pending review